Sergio Montes Selected Research

1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)

1/2022	The C-terminal domain of the heavy chain of tetanus toxin prevents the oxidative and nitrosative stress induced by acute toxicity of 1-methyl-4-phenylpyridinium, a rat model of Parkinson's disease.
6/2017	Copper sulfate pretreatment prevents mitochondrial electron transport chain damage and apoptosis against MPP+-induced neurotoxicity.
1/2015	Neuroprotective effect of Buddleja cordata methanolic extract in the 1-methyl-4-phenylpyridinium Parkinson's disease rat model.
4/2009	Effect of EGb761 supplementation on the content of copper in mouse brain in an animal model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sergio Montes Research Topics

Disease

14	Parkinson Disease (Parkinson's Disease) 01/2022 - 08/2008
8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 07/2010
6	Fibrosis (Cirrhosis) 12/2018 - 02/2002
4	Hepatic Encephalopathy 12/2020 - 12/2011
3	Body Weight (Weight, Body) 01/2020 - 03/2013
3	Huntington Disease (Huntington's Disease) 09/2017 - 01/2013
3	Spinal Cord Injuries (Spinal Cord Injury) 12/2016 - 01/2007
3	Brain Ischemia (Cerebral Ischemia) 01/2014 - 11/2008
2	Pain (Aches) 01/2022 - 01/2021
2	Liver Diseases (Liver Disease) 12/2020 - 01/2019
2	Delirium 11/2019 - 07/2008
2	Nervous System Diseases (Neurological Disorders) 09/2017 - 06/2004
2	Infarction (Infarctions) 01/2016 - 02/2010
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2014 - 05/2003
2	Ischemia 02/2010 - 11/2008
2	Stroke (Strokes) 02/2010 - 01/2005
2	Psychotic Disorders (Schizoaffective Disorder) 08/2008 - 07/2008
2	Mental Disorders (Mental Disorder) 08/2008 - 07/2008
1	Musculoskeletal Pain 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 08/2021
1	Neoplasms (Cancer) 08/2021
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Brain Neoplasms (Brain Tumor) 11/2020
1	Polyneuropathies (Polyneuropathy) 01/2020
1	Diabetes Mellitus 01/2020
1	Hyperalgesia 01/2020
1	Neuralgia (Stump Neuralgia) 01/2020
1	Insulin Resistance 01/2020
1	Schizophrenia (Dementia Praecox) 10/2019
1	Dyskinesias (Dyskinesia) 06/2019
1	Alzheimer Disease (Alzheimer's Disease) 04/2019
1	Dementia (Dementias) 04/2019
1	Cholestasis 01/2019
1	Inflammation (Inflammations) 12/2018

Drug/Important Bio-Agent (IBA)

9	Dopamine (Intropin)FDA LinkGeneric 08/2021 - 07/2008
7	ManganeseIBA 12/2020 - 02/2002
6	AntioxidantsIBA 11/2021 - 11/2008
5	CopperIBA 01/2021 - 04/2009
5	Glutamine (L-Glutamine)FDA Link 12/2020 - 06/2003
4	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 01/2022 - 04/2009
4	Neurotransmitter Agents (Neurotransmitter)IBA 12/2016 - 01/2007
4	Neuroprotective AgentsIBA 01/2015 - 11/2008
4	IronIBA 01/2014 - 07/2010
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 08/2021 - 01/2005
3	Serotonin (5 Hydroxytryptamine)IBA 08/2021 - 08/2008
3	AmmoniaIBA 12/2020 - 05/2012
3	Glutamic Acid (Glutamate)FDA Link 06/2019 - 01/2007
3	Dehydroepiandrosterone (DHEA)IBA 10/2009 - 07/2008
3	NitratesIBA 05/2007 - 05/2003
2	Tetanus ToxinIBA 01/2022 - 04/2019
2	CadmiumIBA 01/2022 - 01/2021
2	CatecholaminesIBA 08/2021 - 07/2002
2	CytokinesIBA 12/2020 - 01/2002
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2013
2	EnzymesIBA 01/2020 - 12/2016
2	Insulin (Novolin)FDA Link 01/2020 - 03/2013
2	Streptozocin (Streptozotocin)FDA Link 01/2020 - 01/2016
2	Monoamine Oxidase (MAO)IBA 01/2020 - 10/2009
2	Homovanillic AcidIBA 11/2019 - 07/2008
2	gamma-Aminobutyric Acid (GABA)IBA 06/2019 - 01/2007
2	Dapsone FDA Link 03/2011 - 11/2008
2	Drinking WaterIBA 06/2009 - 02/2002
2	SteroidsIBA 08/2008 - 07/2008
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2022
1	Morphine (MS Contin)FDA LinkGeneric 01/2022
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 11/2021
1	Acetates (Acetic Acid Esters)FDA Link 11/2021
1	5,8,11,14-heneicosatetraynoic acidIBA 11/2021
1	AcidsIBA 08/2021
1	3,4-Dihydroxyphenylacetic AcidIBA 08/2021
1	Catecholamine ReceptorsIBA 08/2021
1	Mixed Function Oxygenases (Monooxygenases)IBA 08/2021
1	Essential Fatty AcidsIBA 01/2021
1	estradiol 3-benzoate (estradiol benzoate)IBA 12/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	NAD (NADH)IBA 01/2020
1	Dopamine AntagonistsIBA 11/2019
1	Clozapine (Clozaril)FDA LinkGeneric 10/2019
1	norclozapineIBA 10/2019
1	Dialysis SolutionsIBA 06/2019
1	Oxidopamine (6 Hydroxydopamine)IBA 06/2019
1	Levodopa (L Dopa)FDA LinkGeneric 06/2019
1	4-(1H-imidazol-4-ylmethyl)piperidineIBA 06/2019
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 06/2019
1	Amyloid beta-PeptidesIBA 04/2019
1	Pramipexole (Mirapex)FDA LinkGeneric 04/2019
1	naringeninIBA 01/2019
1	FlavonoidsIBA 01/2019
1	Thioacetamide (Thioacetamid)IBA 12/2018
1	TeaIBA 12/2018
1	CarbonIBA 12/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2018

Therapy/Procedure

2	Ligation 06/2009 - 01/2006
1	Therapeutics 01/2022
1	Radiotherapy 11/2020
1	Denervation 01/2020
1	Injections 01/2020